Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 1
A trial of SRA737 with gemcitabine and cisplatin or gemcitabine alone for cancer that has spread or continued to grow after treatment (advanced cancer).
It is for people with any type of cancer apart from those of the blood or lymphatic system such as:
Recruitment start: 10 June 2016
Recruitment end: 2 July 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Udai Banerji
Sierra Oncology, Inc.
Experimental Cancer Medicines Centre (ECMC)
Last reviewed: 01 Jul 2019
CRUK internal database number: 14116